GSK_Annual_Report_2021

Notes to the Consolidated Financial Statements for the year ended March 31, 2021 (contd.) Annual Report 2020-21 193 ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 Note 17 : Other equity Capital redemption reserve 2,62.00 2,62.00 General reserve 778,50.29 778,50.29 Capital reserve 1,70.97 1,70.97 Retained earnings (Including Other Comprehensive Income) 546,84.11 868,36.63 1329,67.37 1651,19.89 Note 18 : Non-current financial liabilities - Borrowings (Unsecured) Interest free deferred sales tax incentive - 2.40 - 2.40 Terms of repayment Interest free deferred sales tax incentive as at March 31, 2021 of ` 2.40 lakhs (March 31, 2020 of ` 17.70 lakhs) availed under the 1993 Sales Tax Deferment Scheme which is repayable in one instalments closing on April 30, 2021. The current maturity amount as at March 31, 2021 is ` 2.40 lakhs (March 31, 2020: ` 15.30 lakhs) of the loan has been disclosed under Note 22. ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 Note 19 : Non-current financial liabilities - Others Security deposits received (Unsecured) 2,05.09 2,06.60 Other non-current financial liabilities 0.72 0.72 Other financial lease liabilities (Refer Note 46) 20,24.99 26,83.72 22,30.80 28,91.04 Note 20 : Non-current provisions For Pricing matters (Refer Note 40, 42 and 25) 123,96.15 123,96.15 For employee benefits (Refer Note 38) Gratuity 16,98.96 24,22.27 Leave encashment and compensated absences 34,94.48 32,07.75 Post retirement medical and other benefits 62,85.22 60,37.58 For long term incentive plan (Refer Note 25 and 52) 2,85.61 3,44.52 For divestment / restructuring (Refer Note 25) 1,92.96 1,92.96 For others (Refer Note 25) 15,96.50 15,73.22 259,49.88 261,74.45